Menu
GWAS Study

Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.

Yu H, Wang L, Lv L et al.

26656879 PubMed ID
GWAS Study Type
1081 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

YH
Yu H
WL
Wang L
LL
Lv L
MC
Ma C
DB
Du B
LT
Lu T
JC
Jin C
YH
Yan H
YY
Yang Y
LW
Li W
RY
Ruan Y
ZH
Zhang H
ZH
Zhang H
MW
Mi W
MB
Mowry B
MW
Ma W
LK
Li K
ZD
Zhang D
YW
Yue W
Chapter II

Abstract

Summary of the research findings

Antipsychotic-induced weight gain (AIWG) is a serious concern in therapy with antipsychotic medications. To identify single nucleotide polymorphisms (SNPs) associated with AIWG, we conducted a genome-wide association study (GWAS) for antipsychotic treatment.

534 Han Chinese ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1081
Total Participants
GWAS
Study Type
Yes
Replicated
547 East Asian ancestry individuals
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.